Ausgabe 6/2014
Inhalt (13 Artikel)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary, John Q. Trojanowski, Julie A. Schneider, Jose F. Abisambra, Erin L. Abner, Irina Alafuzoff, Steven E. Arnold, Johannes Attems, Thomas G. Beach, Eileen H. Bigio, Nigel J. Cairns, Dennis W. Dickson, Marla Gearing, Lea T. Grinberg, Patrick R. Hof, Bradley T. Hyman, Kurt Jellinger, Gregory A. Jicha, Gabor G. Kovacs, David S. Knopman, Julia Kofler, Walter A. Kukull, Ian R. Mackenzie, Eliezer Masliah, Ann McKee, Thomas J. Montine, Melissa E. Murray, Janna H. Neltner, Ismael Santa-Maria, William W. Seeley, Alberto Serrano-Pozo, Michael L. Shelanski, Thor Stein, Masaki Takao, Dietmar R. Thal, Jonathan B. Toledo, Juan C. Troncoso, Jean Paul Vonsattel, Charles L. White 3rd, Thomas Wisniewski, Randall L. Woltjer, Masahito Yamada, Peter T. Nelson
Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process?
Heiko Braak, Kelly Del Tredici
Aβ immunotherapy for Alzheimer’s disease: effects on apoE and cerebral vasculopathy
Kenji Sakai, Delphine Boche, Roxana Carare, David Johnston, Clive Holmes, Seth Love, James A. R. Nicoll
Experimental transmissibility of mutant SOD1 motor neuron disease
Jacob I. Ayers, Susan Fromholt, Morgan Koch, Adam DeBosier, Ben McMahon, Guilian Xu, David R. Borchelt
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist, Oldriska Chutna, Luc Bousset, Patrick Aldrin-Kirk, Wen Li, Tomas Björklund, Zhan-You Wang, Laurent Roybon, Ronald Melki, Jia-Yi Li
Zebrafish models of BAG3 myofibrillar myopathy suggest a toxic gain of function leading to BAG3 insufficiency
Avnika A. Ruparelia, Viola Oorschot, Raquel Vaz, Georg Ramm, Robert J. Bryson-Richardson
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis
Manja Schubert, Debabrata Panja, Mette Haugen, Clive R. Bramham, Christian A. Vedeler
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors
Joshua Mangerel, Aryeh Price, Pedro Castelo-Branco, Jack Brzezinski, Pawel Buczkowicz, Patricia Rakopoulos, Diana Merino, Berivan Baskin, Jonathan Wasserman, Matthew Mistry, Mark Barszczyk, Daniel Picard, Stephen Mack, Marc Remke, Hava Starkman, Cynthia Elizabeth, Cindy Zhang, Noa Alon, Jodi Lees, Irene L. Andrulis, Jay S. Wunder, Nada Jabado, Donna L. Johnston, James T. Rutka, Peter B. Dirks, Eric Bouffet, Michael D. Taylor, Annie Huang, David Malkin, Cynthia Hawkins, Uri Tabori
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells
Mark Barszczyk, Pawel Buczkowicz, Pedro Castelo-Branco, Stephen C. Mack, Vijay Ramaswamy, Joshua Mangerel, Sameer Agnihotri, Marc Remke, Brian Golbourn, Sanja Pajovic, Cynthia Elizabeth, Man Yu, Betty Luu, Andrew Morrison, Jennifer Adamski, Kathleen Nethery-Brokx, Xiao-Nan Li, Timothy Van Meter, Peter B. Dirks, James T. Rutka, Michael D. Taylor, Uri Tabori, Cynthia Hawkins
Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues
Anna Sophie Berghoff, Rupert Bartsch, Adelheid Wöhrer, Berthold Streubel, Peter Birner, Johan M. Kros, Priscilla K. Brastianos, Andreas von Deimling, Matthias Preusser
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody
Walter Maetzler, Andrea Pilotto, Anja Apel, Christian Deuschle, Gabriele Kuebart, Sebastian Heinzel, Inga Liepelt-Scarfone, Claudia Schulte, Dorothee Reusch, Erwin Schleicher, Oliver Rothfuss, Anja Schneider, Richard Dodel, Thomas Gasser, Daniela Berg
Erratum to: Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice
Amanda N. Sacino, Mieu Brooks, Michael A. Thomas, Alex B. McKinney, Nicholas H. McGarvey, Nicola J. Rutherford, Carolina Ceballos-Diaz, Janice Robertson, Todd E. Golde, Benoit I. Giasson